Skip to content

Impact of a Training Program on the Body Composition of Overweight and Obese Young Adults : Concentric Versus Eccentric Exercise

Impact of a Training Program on the Body Composition of Overweight and Obese Young Adults : Concentric Versus Eccentric Exercise

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02938117
Acronym
OPEX
Enrollment
30
Registered
2016-10-19
Start date
2017-01-31
Completion date
2020-01-31
Last updated
2016-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adults, BMI>35

Keywords

obesity, eccentric exercise, body composition, training program

Brief summary

Nowadays, eccentric exercise can be realized in a dynamic way with an ergocycle wich permits eccentric (ECC) lower limbs contractions at a defined power output. With this type of ergometer, O2 consumption (VO2) in ECC is three fold lower than in concentric (CON) for the same power output. Consequently, ECC program could be used in chronic disorders with limited capacities, such as obesity. The investigators hypothesis that an eccentric training program, as it will induce higher mechanical constraints, would improve body composition, especially by reducing fat mass. This effect could be explained by an increased rest energy expenditure and a better improvement in biological parameters (particularly lipid profile and insulin-resistance) after ECC training (versus CON training). This study aims to compare the modification of fat mass after an ECC program versus a CON program at the same VO2. The secondary goal is to assess the physiological mechanisms involved in the modification of body composition

Detailed description

Thirty adults will be randomized into 2 groups: CON or EXC. The patients of ECC group will follow habituation sessions (2weeks) to avoid the secondary muscular effects of high intensity eccentric exercise. The training program will last 12 weeks for the two groups. Before and after, each subjects will participate to the following measurements: total and segmental body composition (DXA), aerobic capacities (maximal incremental exercise test, VO2max), muscular lower limbs strength (isometric end isokinetic dynamometer), rest energy expenditure (indirect calorimetry), biological parameters (lipid profile, insulin-resistance), physical activity (actimetry), food intakes and quality of life (questionnaires).

Interventions

Sponsors

University Hospital, Clermont-Ferrand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* \- Adults * Obese (BMI\>35) * Inactive (\<10 METS/h/week) * No other chronic disease (cardio pulmonary, osteo articulary or muscular diseases), no surgery during the last 3 months, no contraindication to physical activity

Exclusion criteria

* (BMI\<35)

Design outcomes

Primary

MeasureTime frame
change in total body fat mass (Dual X ray Absorptiometry)before and after the 12 weeks training program

Secondary

MeasureTime frameDescription
isometric muscular lower limbs strengthbefore and after the 12 weeks training program
isokinetic muscular lower limbs strengthbefore and after the 12 weeks training program
rest energy expenditure (indirect calorimetry)before and after the 12 weeks training program
biological parameters (plasma lipid profile)before and after the 12 weeks training program
aerobic capacities (VO2max)before and after the 12 weeks training program
physical activitybefore and after the 12 weeks training program(questionnaires)
food intakesbefore and after the 12 weeks training program(measurements)
quality of life (questionnaires)before and after the 12 weeks training program
segmental body compositionbefore and after the 12 weeks training program(segmental fat and fat free mass)
biological parameters (insulin-resistance)before and after the 12 weeks training program

Countries

France

Contacts

Primary ContactPatrick LACARIN
placarin@chu-clermontferrand.fr04 73 75 11 95

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026